β-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma

Abstract Aim β-Carotene has shown cancer-preventive effects in preclinical studies while increasing lung cancer mortality in clinical trials. We have shown that β-carotene stimulates cAMP signalling in vitro . Here, we have tested the hypothesis that β-carotene promotes the development of pulmonary...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 45; no. 7; pp. 1257 - 1264
Main Authors Al-Wadei, Hussein A.N, Schuller, Hildegard M
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.05.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aim β-Carotene has shown cancer-preventive effects in preclinical studies while increasing lung cancer mortality in clinical trials. We have shown that β-carotene stimulates cAMP signalling in vitro . Here, we have tested the hypothesis that β-carotene promotes the development of pulmonary adenocarcinoma (PAC) in vivo via cAMP signalling. Methods PAC was induced in hamsters with the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), followed by β-carotene for 1.5 years. Incidence, multiplicity and size of lung tumours were recorded, and phosphorylated CREB and ERK1/2 in tumour cells were determined by Western blots. Cyclic AMP in blood cells was analysed by immunoassays, retinoids in serum and lungs by HPLC. Results β-Carotene increased lung tumour multiplicity, lung tumour size, blood cell cAMP, serum and lung levels of retinoids and induced p-CREB and p-ERK1/2 in lung tumours. Conclusions Our data suggest that β-carotene promotes the development of PAC via increased cAMP signalling.
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2008.10.035